United States

Endologix Inc (ELGX.OQ)

ELGX.OQ on NASDAQ Stock Exchange Global Select Market

10:49am EDT
Change (% chg)

$0.11 (+0.98%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ELGX.OQ


Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company’s products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms: traditional minimally invasive endovascular repair... (more)


Beta: 0.64
Market Cap(Mil.): $916.65
Shares Outstanding(Mil.): 81.77
Dividend: --
Yield (%): --


  ELGX.OQ Industry Sector
P/E (TTM): -- 121.58 39.76
EPS (TTM): -0.74 -- --
ROI: -20.03 10.80 12.39
ROE: -44.34 12.87 13.27
Search Stocks

BRIEF-Endologix gets CE mark for Nellix Endovascular Aneurysm Sealing system

* Endologix announces CE mark for next-generation Nellix Endovascular Aneurysm Sealing system

Apr 11 2016

BRIEF-Acacia Research says its units entered into settlement and license agreement with Endologix Inc

* Subsidiaries of company entered into a settlement and license agreement with Endologix Inc

Mar 22 2016


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Stock Traders Daily
Provider : New Constructs, LLC
Provider : ValuEngine, Inc.
Provider : S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks